← Back to Search

Behavioural Intervention

Physical Activity Program for Breast and Colon Cancer Survivors

N/A
Recruiting
Led By Prinipcal Investigator
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if using a physical activity index screener, exercise coaching, and self-monitoring can help breast or colon cancer patients increase physical activity and reduce time spent sitting or being inactive."

Who is the study for?
This trial is for breast and colon cancer survivors who are interested in increasing their physical activity. Participants should be willing to use educational materials, wear an activity tracker, complete health surveys, and possibly receive exercise coaching calls.
What is being tested?
The study tests if a Physical Activity Index screener combined with exercise coaching and self-monitoring can help survivors of breast or colon cancer become more active and spend less time sitting.
What are the potential side effects?
Since this trial focuses on physical activity, side effects may include typical exercise-related issues such as muscle soreness or fatigue. However, these activities are generally safe and beneficial for most people.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Eligible Participants - Participation Rate
Number of Participants Who Complete Study Questionnaires - Retention
Percentage of Participants to Complete Exercise Sessions - Adherence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient Intervention ArmExperimental Treatment7 Interventions
Participants randomized into the intervention arm will receive a pre-exercise screening call about two weeks after enrolling into the study and complete the six (6) study visits and pre-determined test and procedures for the patient intervention arm.
Group II: Waitlist Control ArmActive Control6 Interventions
Participants randomized to the waitlist control arm, will have vitals collected and complete surveys at the first (baseline), 3-month, and 6-month visits pre-determined test and procedures for the waitlist control arm. The pre-exercise consultation will begin after the 6-month visit.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,898 Previous Clinical Trials
41,012,693 Total Patients Enrolled
946 Trials studying Breast Cancer
1,545,578 Patients Enrolled for Breast Cancer
Wake Forest University Health SciencesLead Sponsor
1,372 Previous Clinical Trials
2,382,405 Total Patients Enrolled
38 Trials studying Breast Cancer
1,346,528 Patients Enrolled for Breast Cancer
Prinipcal InvestigatorPrincipal InvestigatorWake Forest Baptist Comprehensive Cancer Center
~13 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top